Advertisement

Cornelia de Lange Syndrome: Diagnosis, Features & Care

Comprehensive guide to Cornelia de Lange Syndrome: understanding diagnosis, clinical features, and management strategies.

By Medha deb
Created on

Cornelia de Lange Syndrome: Overview and Clinical Significance

Cornelia de Lange Syndrome (CdLS) is a rare genetic disorder that affects multiple body systems and is typically apparent at birth. The condition is characterized by distinctive facial features, growth delays, upper limb anomalies, and intellectual disability of varying severity. CdLS exists on a clinical spectrum, ranging from mild to severe presentations, with the classic form representing the most recognizable and severely affected phenotype.

First described by Brachmann in the early twentieth century and later characterized in detail by Cornelia de Lange, this syndrome has become better understood through advances in molecular genetics and clinical recognition. The disorder affects approximately 1 in 10,000 to 30,000 live births, though the exact prevalence remains uncertain due to diagnostic variability worldwide.

Genetic Basis and Inheritance Patterns

CdLS is caused by variants in any one of seven genes, all of which encode proteins with structural or regulatory functions in the cohesin complex. The cohesin complex plays a critical role in chromosome cohesion, DNA repair, and gene regulation during development. Mutations in these genes disrupt normal developmental processes, leading to the characteristic features of CdLS.

The classic form of CdLS specifically requires a positive finding of mutations in the NIPBL gene, which encodes the Nipped-B-like protein, a component of the cohesin loading complex. Non-classic forms of the syndrome can result from mutations in other cohesin-related genes, leading to variable clinical presentations.

Most cases of CdLS are inherited in an autosomal dominant pattern, though variable expressivity is common. Some cases arise from de novo mutations in affected individuals with unaffected parents.

Clinical Features and Diagnostic Criteria

Characteristic Facial Features

Children with CdLS present with a distinctive facial appearance that aids in clinical recognition. Key craniofacial features include:

  • Unusually small, short head (microbrachycephaly)
  • Prominent vertical groove between the upper lip and nose (philtrum)
  • Depressed nasal bridge with upturned nostrils (anteverted nares)
  • Small chin (micrognathia)
  • Thin, downturned lips
  • Low-set ears
  • Thick, arched eyebrows that meet across the base of the nose (synophrys)
  • Unusually low hairline on the forehead and back of the neck
  • Curly, unusually long eyelashes
  • Widely spaced teeth

Growth and Physical Development

Affected individuals demonstrate prenatal and postnatal growth delays. Most newborns with CdLS experience prenatal onset growth failure, with continuing postnatal deficiencies in height, weight, and head circumference below the fifth percentile throughout life. Infants frequently present with low birth weight and failure to thrive, failing to gain weight or grow at expected rates during early childhood.

Upper Limb Anomalies

Distinctive malformations of the hands and arms are hallmark features of CdLS. These include:

  • Unusually small hands and feet
  • Inward deviation of the fifth fingers (clinodactyly)
  • Webbing of certain toes (syndactyly)
  • Skeletal abnormalities involving missing digits (oligodactyly)
  • Reduction defects with absent forearms alone
  • Less commonly, complete absence of forearms, hands, and fingers

Intellectual Disability and Development

Most individuals with classic CdLS present with severe to profound intellectual disability. IQ scores typically range from 30 to 86, with a mean of 53. Developmental delays are evident in the acquisition of psychomotor skills and cognitive milestones. A CdLS developmental chart is available to monitor progress and compare developmental trajectories against other affected individuals.

Many affected children demonstrate behavioral challenges, including self-stimulation, self-destructive tendencies, hyperactivity, and other behavioral problems similar to autism spectrum presentations. However, despite decreased facial expression based on emotion, affected children typically respond positively to certain stimuli, such as fast movements.

Additional Systemic Features

CdLS affects numerous organ systems beyond craniofacial and limb structures:

  • Gastrointestinal: Early feeding difficulties, vomiting, gastroesophageal reflux, and swallowing difficulties
  • Cardiac: Cardiac septal defects and other congenital heart abnormalities
  • Respiratory: Feeding and breathing difficulties, increased susceptibility to respiratory infections, low-pitched “growling” cry, low voice
  • Neurological: Seizures, hearing loss, muscle weakness (hypotonia), motor delays
  • Skeletal: Delayed skeletal maturation, scoliosis, kyphosis, pectus carinatum
  • Cutaneous: Excessive body hair growth (hirsutism or hypertrichosis)
  • Ocular: Vision abnormalities, strabismus, nystagmus, cataracts
  • Genitourinary: Genital abnormalities in males

Diagnostic Approach

Clinical Diagnosis

Clinical diagnosis of CdLS relies on recognition of the characteristic combination of facial features, growth delays, upper limb anomalies, and intellectual disability. A thorough clinical history and physical examination documenting diagnostic features and physical findings form the foundation of assessment. Diagnostic criteria have been established for both classic and non-classic CdLS phenotypes by international expert consensus.

Molecular Testing

Confirmation of classic CdLS diagnosis requires a positive finding of mutations in the NIPBL gene. Recent advances in next-generation sequencing (NGS) have significantly improved molecular diagnostics and allow simultaneous screening of all seven known CdLS genes. However, marked heterogeneity exists in clinical and molecular diagnostic approaches worldwide, making standardized testing recommendations important for consistency and cost-effectiveness.

Suggested Evaluation Components

A comprehensive diagnostic evaluation should include:

  • Detailed clinical history and examination describing diagnostic features
  • Laboratory studies including molecular genetic testing
  • Developmental assessment or psychological testing to evaluate intellectual and cognitive impairment
  • Imaging studies as clinically indicated

Management and Treatment

Current Treatment Limitations

There is currently no cure for CdLS. Treatment and management are entirely symptomatic and supportive, aimed at optimizing quality of life and addressing specific complications as they arise.

Comprehensive Care Coordination

CdLS is a complex disorder affecting many body systems, making it essential that a lead clinician is identified for each patient to ensure coordination of the numerous aspects of care in both childhood and adulthood. This multidisciplinary approach involves coordination among various specialists including pediatrics, genetics, gastroenterology, cardiology, neurology, otolaryngology, ophthalmology, and developmental pediatrics.

Specific Management Strategies

Nutritional Support: Feeding difficulties are common, particularly in infancy. Management may include gastrostomy tube placement for nutrition when oral feeding is insufficient. Careful monitoring of growth using CdLS-specific growth charts helps identify adequacy of nutritional intake.

Gastroesophageal Reflux: Reflux disease is frequently encountered and managed with appropriate medical interventions, including proton pump inhibitors or H2-receptor antagonists, and sometimes requires surgical intervention (fundoplication).

Seizure Management: Seizures occur in a significant proportion of affected individuals and are managed with anticonvulsant medications tailored to seizure type and individual tolerance.

Respiratory Care: Aggressive management of respiratory infections and aspiration precautions are important, as death most commonly relates to aspiration pneumonia. Speech-language pathology evaluation and swallowing studies may guide safe feeding practices.

Developmental Support: Early intervention programs, special education services, and behavioral support strategies address developmental delays and behavioral challenges. Psychomotor development monitoring using standardized CdLS developmental charts guides intervention planning.

Surgical Interventions: Cardiac surgery may be necessary for structural defects. Orthopedic interventions address skeletal abnormalities such as scoliosis when indicated.

Long-Term Prognosis and Lifespan

Life expectancy for individuals with CdLS varies based on the severity of features, particularly cardiac involvement and aspiration risk. While some individuals with milder presentations reach normal or near-normal lifespan, those with classic CdLS face greater medical complexity. Aspiration pneumonia represents the most common cause of mortality, emphasizing the importance of careful airway protection and swallowing management throughout life.

Individuals who survive childhood generally continue to experience significant developmental and physical limitations. Ongoing medical management, preventive care, and multidisciplinary support optimize outcomes across the lifespan.

Frequently Asked Questions

Q: Is Cornelia de Lange Syndrome inherited?

A: Yes, CdLS is typically inherited in an autosomal dominant pattern, meaning only one mutated copy of a gene is needed to cause the disorder. However, many cases arise from de novo mutations in affected individuals with unaffected parents. Genetic counseling is recommended for families with confirmed CdLS.

Q: Can CdLS be diagnosed prenatally?

A: CdLS can sometimes be suspected prenatally through ultrasound findings such as growth restriction and limb anomalies. However, definitive prenatal diagnosis requires molecular testing for gene mutations. Many cases are diagnosed after birth based on clinical features.

Q: What is the difference between classic and non-classic CdLS?

A: Classic CdLS is caused by mutations in the NIPBL gene and is characterized by more severe and recognizable features. Non-classic CdLS results from mutations in other cohesin-related genes and typically presents with milder features and less severe intellectual disability.

Q: Can individuals with CdLS live independently?

A: Most individuals with classic CdLS require ongoing support due to intellectual disability and medical complexity. Those with milder, non-classic presentations may achieve greater independence with appropriate educational and behavioral supports. Individual outcomes vary significantly.

Q: What should families expect regarding long-term care?

A: Families should expect lifelong medical and developmental needs requiring coordination with multiple specialists. Early intervention, special education, and comprehensive medical management are essential. Support groups and disease-specific resources provide valuable guidance for families navigating CdLS care.

References

  1. POMS: DI 23022.710 – Cornelia de Lange Syndrome–Classic Form — Social Security Administration. 2020-08. https://secure.ssa.gov/apps10/poms.nsf/lnx/0423022710
  2. Cornelia de Lange Syndrome – Symptoms, Causes, Treatment — National Organization for Rare Disorders (NORD). 2024. https://rarediseases.org/rare-diseases/cornelia-de-lange-syndrome/
  3. Cornelia de Lange Guideline — ERN ITHACA (European Reference Network on Intellectual Disability, Telehealth, Autism and Congenital Anomalies). 2024. https://ern-ithaca.eu/guidelines/ern-ithaca-guidelines/cornelia-de-lange-guideline/
  4. Cornelia de Lange Syndrome – GeneReviews® — National Center for Biotechnology Information (NCBI). 2024. https://www.ncbi.nlm.nih.gov/books/NBK1104/
  5. Cornelia de Lange syndrome: Clinical review, diagnostic and molecular approaches — American Journal of Medical Genetics. 2010. https://onlinelibrary.wiley.com/doi/full/10.1002/ajmg.a.31757
Medha Deb is an editor with a master's degree in Applied Linguistics from the University of Hyderabad. She believes that her qualification has helped her develop a deep understanding of language and its application in various contexts.

Read full bio of medha deb